Suppr超能文献

氢氧化铝治疗胆盐性腹泻。

Aluminium hydroxide in bile-salt diarrhoea.

作者信息

Sali A, Murray W R, MacKay C

出版信息

Lancet. 1977 Nov 19;2(8047):1051-3. doi: 10.1016/s0140-6736(77)91884-0.

Abstract

The treatment of choleraic diarrhoea remains a problem. Cholestyramine is effective but long-term treatment is often impracticable. In-vitro studies have shown that aluminium hydroxide has bile-acid-binding properties comparable with those of cholestyramine. The bile-acid-binding properties of aluminium hydroxide have now been investigated in vivo and applied to the treatment of patients with choleraic diarrhoea. Aluminium hydroxide increased the faecal bile-salt concentration of patients with a normal bowel habit whereas magnesium hydroxide had no effect. Eight patients with severe choleraic diarrhoea were treated with aluminium-hydroxide suspension: bowel motion became less frequent and daily faecal weight fell.

摘要

霍乱性腹泻的治疗仍然是个问题。消胆胺有效,但长期治疗往往不切实际。体外研究表明,氢氧化铝具有与消胆胺相当的胆汁酸结合特性。现已对氢氧化铝的胆汁酸结合特性进行了体内研究,并将其应用于霍乱性腹泻患者的治疗。氢氧化铝可提高排便习惯正常患者的粪便胆汁盐浓度,而氢氧化镁则无此作用。8例重症霍乱性腹泻患者接受了氢氧化铝混悬液治疗:排便次数减少,每日粪便重量下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验